A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. (Q30377443)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
scientific article

    Statements

    A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. (English)
    Susan C DiLorenzo
    Grace L Chen
    17 April 2009
    3744-3753

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit